Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 6258 of 6351
-
New drug CKD-508 tested for safety in healthy people
Knowledge-focused CompletedThis Phase 1, randomized, parallel-group, placebo-controlled, double-blinded study aims to evaluate the safety, PK, and PD of CKD-508 when administered multiple times once daily to healthy participants.
Phase 1 • Sponsor: Chong Kun Dang Pharmaceutical • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Prediabetes drug study pulled before it began
Disease control CancelledThe goal of this clinical trial is to investigate whether metformin improves vascular function in individuals with prediabetes. The main questions it aims to answer are: 1. Does metformin improve large conduit artery endothelial function in individuals with prediabetes? 2. Does …
Phase 2 • Sponsor: Diana Jalal • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New drug ZP9830 enters first human safety study
Knowledge-focused Recruiting nowThe primary object in this research study is to investigate the safety and tolerability of ZP9830 in healthy study participants, and in addition, the study will investigate how ZP9830 works in the body (pharmacokinetics, PK and pharmacodynamics, PD) compared to placebo.
Phase 1 • Sponsor: Zealand Pharma • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
New drug ABBV-CLS-616 tested for safety in healthy people
Knowledge-focused CompletedThis is a Phase 1, first in human, randomized, four-part study to investigate the safety, tolerability, and pharmacokinetics of ABBV-CLS-616 after oral dosing in healthy volunteers.
Phase 1 • Sponsor: AbbVie • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Stem cell trial for rare bleeding disorder pulled before it began
Disease control CancelledThis study is a clinical study initiated by single-arm, single-center, multiple administration researchers. The main purpose of this study is to evaluate the safety and efficacy of mesenchymal stem cells in refractory ITP subjects. The subjects voluntarily signed the informed con…
Sponsor: Guangzhou Bio-gene Technology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Cricket flour snacks put to the test: do they really curb hunger?
Knowledge-focused CompletedThis randomized, single-blind, triple crossover study investigated the effects of baked snacks containing either cricket flour (Acheta domesticus), pea flour (both at 15%), or a wheat flour-based control. One hundred adult participants were recruited and consumed each of the thre…
Sponsor: University of Turin, Italy • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
New drug LY4005130 tested in healthy people for first time
Knowledge-focused CompletedThe purpose of this study is to evaluate how well LY4005130 is tolerated and what side effects may occur in healthy participants. The study drug will be administered either subcutaneously (SC) (under the skin) or intravenously (IV) (into a vein in the arm). Blood tests will be pe…
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New drug PRX019 takes first step: safety check in healthy people
Knowledge-focused CompletedThe purpose of this study is to assess the safety and tolerability of PRX019 in healthy adult participants.
Phase 1 • Sponsor: Prothena Biosciences Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Do emails and texts get people to join gut health research?
Knowledge-focused CompletedThis study is a randomized controlled trial nested in the "Le French Gut" e-cohort aiming to test the efficacy of 4 reminder strategies (emails and/or SMS with standard and/or institutional wording) in increasing participation of inactive volunteers. This trial is led in collabo…
Sponsor: SKEZI • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Simple Eye-Closing trick may sharpen Pre-Surgery measurements
Knowledge-focused Recruiting nowCataract surgery is one of the most common performed surgeries in the world. While in the early beginnings of cataract surgery, visual rehabilitation was the main goal of the procedure, refractive outcome and subsequent relative spectacles independency is gaining increasing impor…
Sponsor: Vienna Institute for Research in Ocular Surgery • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
New drug ALN-AGT01 RVR tested for safety in healthy people
Knowledge-focused CompletedThe purpose of this study is to evaluate the safety, tolerability and PK of single ascending doses of ALN-AGT01 RVR.
Phase 1 • Sponsor: Alnylam Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:50 UTC
-
Pfizer compares two pill forms of new drug in small Healthy-Volunteer study
Knowledge-focused CompletedThe primary purpose of this study is to measure and compare the amount of study drug in your blood after a single dose of two formulations of study drug.
Phase 1 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Healthy volunteers help Fine-Tune new drug formulation
Knowledge-focused CompletedPart 1 aims to investigate the relative bioavailability of a new formulation and to assess potential food effects following oral administration of SYT-510. Part 1 will then guide dosing in Part 2, a multiple dose study which aims to assess safety, tolerability and pharmacokinetic…
Phase 1 • Sponsor: Synendos Therapeutics AG • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
New antibiotic combo tested in healthy volunteers
Knowledge-focused CompletedThis was a Phase 1, open-label, single-center Pharmacokinetic (PK) study to evaluate plasma and intrapulmonary pharmacokinetics (PK) of ceftibuten and ledaborbactam in healthy adult participants. Approximately 31 participants were planned to be enrolled in two groups, with appro…
Phase 1 • Sponsor: Basilea Pharmaceutica • Aim: Knowledge-focused
Last updated Aug 26, 2026 00:00 UTC
-
Breathing muscle training may boost tongue power, small study hints
Knowledge-focused Recruiting nowThis study aims to investigate the effects of respiratory muscle training on tongue muscle function in healthy subjects. We hypothesize that respiratory muscle training can improve strength and endurance of the tongue muscles.
Sponsor: Université Catholique de Louvain • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
When you eat matters: study reveals meal Timing's impact on metabolism
Knowledge-focused CompletedThe overarching aim of this research is to study the effects of caloric content and timing of meals on measures of postprandial metabolism and cardiovascular response 1. Determine the effect of caloric content on measures of postprandial metabolic flexibility and pulse wave anal…
Sponsor: George Washington University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Rare disease study pulled before starting: scientists sought clues in cell stress
Knowledge-focused CancelledMutations in the genes encoding cytosolic aminoacyl-tRNA synthetases are responsible for early-onset multisystemic diseases including to varying degrees interstitial lung disease, liver damage, neurological and digestive disorders, and systemic inflammation. These are rare and se…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Which exercise boosts balance and jumping more for couch potatoes?
Knowledge-focused CompletedThe aim of this study was to compare the effects of Open Kinetic Chain (OKC) and Closed Kinetic Chain (CKC) exercises on dynamic balance, static balance, and vertical jump performance in sedentary individuals. A total of 68 sedentary individuals voluntarily participated in this …
Sponsor: Lokman Hekim University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
New drug CDX-622 tested for safety in healthy people
Knowledge-focused CompletedThis is a study to determine the safety of CDX-622 in healthy participants.
Phase 1 • Sponsor: Celldex Therapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Heart risk study for leg artery patients pulled before start
Knowledge-focused CancelledPeripheral artery disease, lack or blood flow to the legs, has a high prevalence in the Veteran population. In patients with severe peripheral artery disease that requires an endovascular or surgical intervention for lower leg revascularization, the long-term mortality of approxi…
Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC